PL403636A1 - Zastosowanie preparatu fosfolipidowego z zóltka jaja - Google Patents
Zastosowanie preparatu fosfolipidowego z zóltka jajaInfo
- Publication number
- PL403636A1 PL403636A1 PL403636A PL40363613A PL403636A1 PL 403636 A1 PL403636 A1 PL 403636A1 PL 403636 A PL403636 A PL 403636A PL 40363613 A PL40363613 A PL 40363613A PL 403636 A1 PL403636 A1 PL 403636A1
- Authority
- PL
- Poland
- Prior art keywords
- egg yolk
- phospholipid
- preparation
- lecithin
- super
- Prior art date
Links
- 102000002322 Egg Proteins Human genes 0.000 title abstract 3
- 108010000912 Egg Proteins Proteins 0.000 title abstract 3
- 235000013345 egg yolk Nutrition 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 210000002969 egg yolk Anatomy 0.000 title abstract 2
- 150000003904 phospholipids Chemical class 0.000 title abstract 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 229940067606 lecithin Drugs 0.000 abstract 2
- 235000010445 lecithin Nutrition 0.000 abstract 2
- 239000000787 lecithin Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000006978 adaptation Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 210000000991 chicken egg Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011301 standard therapy Methods 0.000 abstract 1
- 230000009469 supplementation Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Wynalazek dotyczy zastosowania preparatu fosfolipidowego z żółtka jaja, zwłaszcza kurzego - super lecytyny, jako składnika leku albo jako substancji czynnej do wytwarzania leków do leczenia reakcji na ciężki stres oraz zaburzeń adaptacyjnych. Wynalazek dotyczy również zastosowania super lecytyny jako suplementu diety, dodatku żywieniowego lub jako składnika preparatów złożonych do stosowania w profilaktyce i uzupełnieniu standardowej terapii leczenia tych chorób.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL403636A PL227503B1 (pl) | 2013-04-22 | 2013-04-22 | Zastosowanie preparatu fosfolipidowego z żółtka jaja |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL403636A PL227503B1 (pl) | 2013-04-22 | 2013-04-22 | Zastosowanie preparatu fosfolipidowego z żółtka jaja |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL403636A1 true PL403636A1 (pl) | 2013-11-25 |
| PL227503B1 PL227503B1 (pl) | 2017-12-29 |
Family
ID=49626535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL403636A PL227503B1 (pl) | 2013-04-22 | 2013-04-22 | Zastosowanie preparatu fosfolipidowego z żółtka jaja |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL227503B1 (pl) |
-
2013
- 2013-04-22 PL PL403636A patent/PL227503B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL227503B1 (pl) | 2017-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500732A1 (en) | Infant formula with special lipid architecture for promoting healthy growth | |
| BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
| PH12017500381A1 (en) | Optimized nutrient food | |
| BR112018000242A2 (pt) | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico | |
| TW201613632A (en) | Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction | |
| MX2018002546A (es) | Composiciones que comprenden un compuesto de urolitina. | |
| BR112015022041A2 (pt) | derivados substituídos de 3-fenilpropilamina para o tratamento de doenças e distúrbios oftálmicas | |
| BR112017020780A2 (pt) | métodos de administração de inibidores de glutaminase | |
| AR104835A1 (es) | Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas | |
| BR112017007138A2 (pt) | composto, medicamento, métodos para reduzir proteína 4 de ligação ao retinol e para a profilaxia ou o tratamento de degeneração macular e/ou uma doença, e, uso de um composto. | |
| MX2021010041A (es) | Composiciones farmaceuticas que comprenden inhibidores de la proteina quinasa akt. | |
| AR105144A1 (es) | Composiciones nutricionales y métodos para promover el desarrollo cognitivo | |
| JP2015533509A5 (pl) | ||
| PH12016501519B1 (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| BR112015029897A2 (pt) | composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição | |
| EA201491427A1 (ru) | Замещенные фенилимидазопиразолы и их применение | |
| BR112017022523A2 (pt) | ?formulação para cápsulas de gel, cápsula de gel, e, processo?. | |
| BR112015024520A2 (pt) | suplemento alimentar e uso do suplemento alimentar | |
| MA40645A (fr) | Préparation prébiotique à base d'inuline | |
| BR112019017314A2 (pt) | composições farmacêuticas para terapia de combinação | |
| IN2014DN09240A (pl) | ||
| MX387178B (es) | Preparaciones de vitaminas que contienen galato de propilo. | |
| PL403636A1 (pl) | Zastosowanie preparatu fosfolipidowego z zóltka jaja | |
| NZ728239A (en) | Immune motifs in products from domestic animals | |
| PH12017500743B1 (en) | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |